Spin-out Merge Labs aims to rival Elon Musk’s firm Neuralink. But researchers say the technology is still at an early stage.

Nexalin’s growing body of published data consistently demonstrates objective normalization of abnormal brain activity and ...

In A Nutshell • A brain stimulation device cleared by the FDA in 2019 failed to beat placebo in a rigorous 150-participant ...

FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical ...

Months after UW Medicine neurosurgeons implanted a first-of-its-kind brain stimulation device in a stroke patient, doctors ...

“To the best of our team's knowledge, this project represents the first time an Alabama medical center has examined deep brain stimulation for depression,” said Matthew Macaluso, D.O., director of the ...

The Picostim-DyNeuMo research system, made by UK company Amber Therapeutics, is an adaptive neurostimulator seated in the skull with two electrodes placed in targeted brain circuits to sense ...

Deep brain stimulation (DBS) involves stimulating certain parts of your brain with implanted electrodes. It’s a promising treatment for treatment-resistant OCD. The main treatments for OCD are talk ...

Research investigating the effects of transcranial direct current stimulation (tDCS) on individuals with depression and ...

A new, large-scale independent UK clinical trial involving 150 children and teenagers found no evidence that TNS improved ...